SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028008
Filing Date
2021-05-14
Accepted
2021-05-14 16:05:50
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-10q_20210331.htm   iXBRL 10-Q 1786665
2 EX-31.1 abcl-ex311_11.htm EX-31.1 20971
3 EX-31.2 abcl-ex312_10.htm EX-31.2 20937
4 EX-32.1 abcl-ex321_8.htm EX-32.1 9459
5 EX-32.2 abcl-ex322_9.htm EX-32.2 9436
6 GRAPHIC gv4rnzlkpfex000001.jpg GRAPHIC 158842
  Complete submission text file 0001564590-21-028008.txt   6388220

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abcl-20210331.xsd EX-101.SCH 40275
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcl-20210331_cal.xml EX-101.CAL 51599
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcl-20210331_def.xml EX-101.DEF 138130
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20210331_lab.xml EX-101.LAB 345959
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20210331_pre.xml EX-101.PRE 260233
12 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10q_20210331_htm.xml XML 951639
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 21924546
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences